Immune Checkpoint Inhibitors Linked to Elevated Myocarditis Risk in NSCLC Patients
A groundbreaking editorial recently published in the latest volume of Oncoscience sheds new light on the complex relationship between immune checkpoint inhibitors (ICIs) and myocarditis,...